EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation

Lova Gani Raju Bandaru, Naresh Konduru iD, Leela Prasad Kowtharapu, Rambabu Gundla iD, Phani Raja Kanuparthy, Naresh Kumar Katari iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.6062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Lova Gani Raju Bandaru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM School of Science, GITAM Deemed to Be University, Hyderabad, India. Hauptthemen laut MEDLINE: Budesonide, Formoterol Fumarate, Drug Contamination. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple LC method has been developed and validated for estimating budesonide (epimer B + A) and formoterol fumarate dihydrate in dry powder inhalation. The development results of this study make it very significant. The degradation and process impurities in EP and ChP were identified in addition to budesonide and formoterol fumarate. As of yet, no one has reported all impurities using a single method. It is a unique research because it analyzes APSD (Aerodynamic Particle Size Distribution), DDU (Delivered Dose Uniformity), BU (Blend Uniformity), Assay, and cleaning test samples. It enhances the quality of medicine and separates all organic impurities and isomers through a suitable stationary phase (YMC‐Pack Pro C18, 150 × 4.6 mm × 3 μm). We optimized the chromatographic conditions: Injection volume was 20 μL, and flow rate was 1.0 mL/min. The wavelength was optimized at 220 nm. After experimental and validation results. An example is A, which contains sodium dihydrogen orthophosphate monohydrate, sodium 1‐decane sulfonate, adjusted pH 3.0, and acetonitrile at a ratio of 80:20 (v/v), and B, which contains pH 3.0 buffer and acetonitrile at a ratio of 20:80 (v/v) respectively. In addition to being optimized, the test method was validated according to ICH Q2(R2).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BudesonideFormoterol FumarateDrug ContaminationReproducibility of ResultsDry Powder InhalersLinear ModelsChromatography, LiquidLimit of DetectionChromatography, High Pressure LiquidPowdersDrug Stability

Stichwörter der Autor:innen

budesonide (epimer)degradation impuritiesformoterol fumarate Dihydrateliquid chromatographyquality by design

Substanzen

BudesonideFormoterol FumaratePowders

Autor:innen und Institutionen

  • Department of Chemistry, GITAM School of Science, GITAM Deemed to Be University, Hyderabad, India.

ORCID-Profile: Naresh Konduru, Rambabu Gundla, Naresh Kumar Katari

Zitieren

APA

Bandaru, L. G. R., Konduru, N., Kowtharapu, L. P., Gundla, R., Kanuparthy, P. R., & Katari, N. K. (2025). Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation. Biomedical Chromatography. https://doi.org/10.1002/bmc.6062

Vancouver

Bandaru LGR, Konduru N, Kowtharapu LP, Gundla R, Kanuparthy PR, Katari NK. Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation. Biomedical Chromatography. 2025. doi:10.1002/bmc.6062

BibTeX
@article{Bandaru2025,
  author = {Bandaru, Lova Gani Raju and Konduru, Naresh and Kowtharapu, Leela Prasad and Gundla, Rambabu and Kanuparthy, Phani Raja and Katari, Naresh Kumar},
  title = {Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.6062}
}
Kostenlos starten →